Otto Yang

Otto Yang

University of California, Los Angeles

H-index: 55

North America-United States

About Otto Yang

Otto Yang, With an exceptional h-index of 55 and a recent h-index of 31 (since 2020), a distinguished researcher at University of California, Los Angeles, specializes in the field of immunology, Viroloy, Immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Chimeric Antigen Receptors against Human Cytomegalovirus

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 …

Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial

Persistent memory despite rapid contraction of circulating T cell responses to SARS-CoV-2 mRNA vaccination

Longitudinal evaluation of antibody persistence in mother-infant dyads after severe acute respiratory syndrome coronavirus 2 infection in pregnancy

NK cell-monocyte crosstalk underlies NK cell activation in severe COVID-19 (preprint)

Direct Detection of 4-Dimensions of SARS-CoV-2: Infection (vRNA), Infectivity (Antigen), Binding Antibody, and Functional Neutralizing Antibody in Saliva

Otto Yang Information

University

Position

Professor

Citations(all)

12756

Citations(since 2020)

4682

Cited By

9879

hIndex(all)

55

hIndex(since 2020)

31

i10Index(all)

166

i10Index(since 2020)

83

Email

University Profile Page

Google Scholar

Otto Yang Skills & Research Interests

immunology

Viroloy

Immunotherapy

Top articles of Otto Yang

Chimeric Antigen Receptors against Human Cytomegalovirus

2024/3/14

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

EClinicalMedicine

2024/3/1

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 …

Annals of Internal Medicine

2024/2/27

Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial

JAMA Network Open

2024/4/1

Persistent memory despite rapid contraction of circulating T cell responses to SARS-CoV-2 mRNA vaccination

Frontiers in immunology

2023/2/13

Longitudinal evaluation of antibody persistence in mother-infant dyads after severe acute respiratory syndrome coronavirus 2 infection in pregnancy

The Journal of infectious diseases

2023/1/15

NK cell-monocyte crosstalk underlies NK cell activation in severe COVID-19 (preprint)

2023

Direct Detection of 4-Dimensions of SARS-CoV-2: Infection (vRNA), Infectivity (Antigen), Binding Antibody, and Functional Neutralizing Antibody in Saliva

Research Square

2023/12/28

IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide

Frontiers in Immunology

2023/12/15

The role of APOBEC3-induced mutations in the differential evolution of monkeypox virus

Virus Evolution

2023/7/1

Vascular and non-HLA autoantibody profiles in hospitalized patients with COVID-19

Frontiers in Immunology

2023/6/15

Predominantly defective CD8+ T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients

Journal of translational medicine

2023/6/8

Vault particles having a modified R8 flexible region

2020/8/13

Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19-A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data

Clinical Infectious Diseases

2022/4/1

Dominant CD8+ T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination

Frontiers in immunology

2022/2/22

Neutralizing Antibody Response and Transplacental Transfer in COVID-19 in Pregnancy

Topics in Antiviral Medicine

2022

Autophagy inducer rapamycin treatment reduces IFN-I–mediated Inflammation and improves anti–HIV-1 T cell response in vivo

JCI insight

2022/11/11

Reply to Viel

Clinical Infectious Diseases

2022/10/15

Early SARS-CoV-2 dynamics and immune responses in unvaccinated participants of an intensely sampled longitudinal surveillance study

Communications medicine

2022/10/11

See List of Professors in Otto Yang University(University of California, Los Angeles)